We showed that fusion proteins containing a human IgG Fc region, such as L-selectin/Fc, can also be captured by CD64/16A, which may provide further options for directing the tissue and tumor antigen targeting of engineered NK cells. This evidence concerns the gene FCGR1A and neoplasm.